FEBNM

Certificate of Fellowship of the European Board of Nuclear Medicine

Treatment ComplicationsEnglish
Exam overview

Practice session

After first-cycle peptide receptor radionuclide therapy, a patient develops persistent nausea, abdominal pain, hypotension, flushing, and wheeze several hours after treatment. What complication should be considered first?

Loading your practice session…